Is propranolol compounding from tablet safe for pediatric use? Results from an experimental test

A. Casiraghi, U. M. Musazzi, I. Franceschini, I. Berti, V. Paragò, L. Cardosi, P. Minghetti

Research output: Contribution to journalArticle

Abstract

Aim: Although propranolol is widely used in the treatment of infantile hemangiomas, the standard 40 mg tablet needs to be fractioned to obtain 10 mg parts, with even lower doses (i.e., 2-3 mg/kg/day divided into 2-3 daily doses) required in infants. This study evaluated the weight and dose uniformity in split quarters of propranolol tablets.

Original languageEnglish
Pages (from-to)355-362
Number of pages8
JournalMinerva Pediatrica
Volume66
Issue number5
Publication statusPublished - Oct 1 2014

    Fingerprint

Keywords

  • Capillary
  • Child
  • Hemangioma
  • Propranolol

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

Cite this

Casiraghi, A., Musazzi, U. M., Franceschini, I., Berti, I., Paragò, V., Cardosi, L., & Minghetti, P. (2014). Is propranolol compounding from tablet safe for pediatric use? Results from an experimental test. Minerva Pediatrica, 66(5), 355-362.